Technical Analysis for TERN - Terns Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
C 22.12 -2.47% -0.56
TERN closed down 2.47 percent on Friday, February 26, 2021, on 15 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
Historical TERN trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
New 52 Week Closing High Bullish -2.47%
New 52 Week Closing High Bullish 0.27%
Multiple of Ten Bullish Other 0.27%
Hot IPO Pullback Bullish Swing Setup 16.24%
Gapped Down Weakness 16.24%
NR7 Range Contraction 8.64%
Inside Day Range Contraction 8.64%
NR7 Range Contraction 8.64%
Older End-of-Day Signals for TERN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Terns Pharmaceuticals, Inc. Description

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and other chronic liver diseases. It develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase 2a clinical trial for the treatment of NASH; and TERN-201, a vascular adhesion protein-1 inhibitor that is in Phase 1 clinical trial for the treatment of NASH. The company also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability; and GLP-1R, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to address metabolic processes involved in the pathogenesis of NASH. Terns Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Foster City, California.


Sector: Other
Industry: Other
Keywords: Biopharmaceutical Organ Systems Steatohepatitis Hepatitis Non Alcoholic Fatty Liver Disease Peptide Hormones Liver Bile Acid Anti Diabetic Drugs Chronic Liver Diseases Glucagon Like Peptide 1 Receptor

Is TERN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 23.68
52 Week Low 14.83
Average Volume 199,607
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 20.76
Average True Range 2.35
ADX 0.0
+DI 27.48
-DI 13.78
Chandelier Exit (Long, 3 ATRs ) 16.63
Chandelier Exit (Short, 3 ATRs ) 21.88
Upper Bollinger Band 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line 0.38
MACD Signal Line 0.12
MACD Histogram 0.2582
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.77
Resistance 3 (R3) 23.86 23.39 23.50
Resistance 2 (R2) 23.39 22.97 23.35 23.40
Resistance 1 (R1) 22.76 22.71 22.53 22.67 23.31
Pivot Point 22.29 22.29 22.18 22.25 22.29
Support 1 (S1) 21.66 21.87 21.43 21.57 20.93
Support 2 (S2) 21.19 21.61 21.15 20.84
Support 3 (S3) 20.56 21.19 20.75
Support 4 (S4) 20.47